Related Experiment Video
Updated: Jan 3, 2026

08:19
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
18.5K
pH-responsive chimeric liposomes: From nanotechnology to biological assessment
Nikolaos Naziris1, Francesca Saitta2, Varvara Chrysostomou3
1Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, Athens 15771, Greece.
International Journal of Pharmaceutics
|November 24, 2019
Summary
Chimeric liposomes, combining phospholipids and pH-responsive polymers, show promise as advanced drug delivery systems. These novel nanocarriers offer enhanced targeting capabilities for improved biomedical applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Liposomes are established biomimetic nano-entities utilized in biomedical applications for disease diagnosis and treatment.
- Conventional liposomes serve as effective drug delivery systems, primarily composed of lipids.
- Recent advancements focus on sophisticated nanotechnological platforms incorporating functional biomaterials for targeted drug delivery.
Purpose of the Study:
- To design and develop novel chimeric liposomes.
- To investigate the morphology, behavior, and properties of these liposomes.
- To assess their potential for biomedical applications, including drug targeting and in vivo evaluation.
Main Methods:
- Chimeric liposomes were formulated using phospholipids and pH-responsive amphiphilic diblock copolymers.
- Morphology and behavior were studied by varying biomaterial concentration, pH, and polymer composition.
- Interactions with biological components, pH-responsiveness, and membrane thermodynamics were assessed.
- Preliminary in vivo toxicity experiments were conducted.
Main Results:
- The study successfully designed and developed chimeric liposomes with tunable properties.
- Formulation parameters significantly influenced the morphology and behavior of the nanosystems.
- The chimeric liposomes demonstrated pH-responsiveness and favorable membrane thermodynamics.
- Preliminary in vivo toxicity data supported the safety profile for further evaluation.
Conclusions:
- Chimeric liposomes represent a sophisticated nanocarrier platform for advanced biomedical applications.
- The rational design incorporating stimuli-responsive polymers enhances drug targeting capabilities.
- Further in vivo studies are warranted to fully establish their therapeutic potential.

